ADVOCACY LETTERS

POSITION PAPERS

Step Therapy Advocacy

NICA believes health plans should consider Step Therapy policies for drugs only when reasonable according to the following criteria – when the Cost of failure is LOW, the TIME to fail is SHORT, and the clinical RISK of failing preferred drugs is LOW.

Read our Step Therapy position paper HERE and visit our Step Therapy advocacy page to learn how you can get involved.

Log in with your credentials

or    

Forgot your details?

Create Account